Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMP-114 added to methotrexate in active rheumatoid arthritis
2005-003436-21Phase 2Terminated
- Sponsor
- Sumitomo Pharma
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rimacalib in rheumatoid arthritis (RA) (3 arms), sponsored by Sumitomo Pharma. Primary endpoints: ACR20 response at Week 24 and ACR20 responder definition. Started Sep 2005; status: terminated.
02
Drugs
rimacalib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-003436-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003436-21.